Author: :Anoma Ranaweera B.V.Sc; PhD (Clinical Biochemistry, University of Liverpool, UK). Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, April 2015.

Posaconazole (Noxafil®; Merck and Co. New Jersey, USA) is an azole antifungal medication indicated for:

How does posaconazole work?

Dosage and administration of posaconazole

Posaconazole is available as:

Prophylaxis of invasive aspergillus and candida infections

Oropharyngeal candidiasis

Azole-resistant oropharyngeal candidiasis

Dosage modifications

Contraindications to treatment with posaconazole

Link to key clinical-trial evidence about posaconazole

Potential drug interactions with posaconazole

What are the adverse effects of posaconazole?

Use of posaconazole in pregnancy

Use of posaconazole in nursing mothers

Use of posaconazole in children

Use of posaconazole in the elderly

New Zealand approved datasheets are the official source of information for these prescription medicines, including approved uses and risk information. Check the individual New Zealand datasheet on the Medsafe website.

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

Submit your images

We are expanding our image library

Contact us

Skin lesion photography

Watch Dr Amanda Oakley presenting "Skin lesion photography" at The Australasian Skin Cancer Congress.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter